Research: Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium
22 Feb, 2018 | 23:31h | UTCProphylactic haloperidol in this population with elevated risk of delirium did not reduce mortality or any of the 15 prespecified secondary outcomes, including delirium incidence, 28-day delirium-free and coma-free days, duration of mechanical ventilation, and ICU and hospital length of stay.